AnteoTech Limited (ASX:ADO)

Market Cap	35.17M
Revenue (ttm)	-545.39K
Net Income (ttm)	-8.72M
Shares Out	2.71B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	122,303
Average Volume	3,377,017
Open	0.0130
Previous Close	0.0140
Day's Range	0.0130 - 0.0140
52-Week Range	0.0070 - 0.0367
Beta	0.88
RSI	64.94
Earnings Date	Aug 27, 2025

About AnteoTech

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, North America, and Latin America. Its products include AnteoBind, s an activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit , a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-ba...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Merrill Gray
• Employees: 99
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ADO

Financial Performance

In 2024, AnteoTech's revenue was 460,397, an increase of 25.89% compared to the previous year's 365,724. Losses were -8.88 million, -29.82% less than in 2023.